"It appears to [provide] a dual-layered benefit to patients," Selvaraju says, referencing the company's suggestion that the drug may make cancer cells more susceptible to chemo and may also contribute to cell death.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs